IL142002A0 - Insulin preparation for pulmonary delivery containing menthol - Google Patents

Insulin preparation for pulmonary delivery containing menthol

Info

Publication number
IL142002A0
IL142002A0 IL14200299A IL14200299A IL142002A0 IL 142002 A0 IL142002 A0 IL 142002A0 IL 14200299 A IL14200299 A IL 14200299A IL 14200299 A IL14200299 A IL 14200299A IL 142002 A0 IL142002 A0 IL 142002A0
Authority
IL
Israel
Prior art keywords
insulin
pulmonary delivery
formulation
insulin preparation
menthol
Prior art date
Application number
IL14200299A
Other languages
English (en)
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of IL142002A0 publication Critical patent/IL142002A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
IL14200299A 1998-10-16 1999-10-15 Insulin preparation for pulmonary delivery containing menthol IL142002A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199801326 1998-10-16
PCT/DK1999/000557 WO2000023099A1 (en) 1998-10-16 1999-10-15 Insulin preparations for pulmonary delivery containing menthol

Publications (1)

Publication Number Publication Date
IL142002A0 true IL142002A0 (en) 2002-03-10

Family

ID=8103609

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14200299A IL142002A0 (en) 1998-10-16 1999-10-15 Insulin preparation for pulmonary delivery containing menthol

Country Status (20)

Country Link
EP (1) EP1121145B1 (uk)
JP (1) JP2002527488A (uk)
KR (1) KR20010080132A (uk)
CN (1) CN1323220A (uk)
AT (1) ATE216258T1 (uk)
AU (1) AU758108B2 (uk)
BR (1) BR9914568A (uk)
CA (1) CA2346884A1 (uk)
CZ (1) CZ20011133A3 (uk)
DE (1) DE69901314T2 (uk)
DK (1) DK1121145T3 (uk)
ES (1) ES2177324T3 (uk)
HU (1) HUP0103606A3 (uk)
IL (1) IL142002A0 (uk)
NO (1) NO20011841L (uk)
PL (1) PL347171A1 (uk)
PT (1) PT1121145E (uk)
UA (1) UA67798C2 (uk)
WO (1) WO2000023099A1 (uk)
ZA (1) ZA200102068B (uk)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001026689A1 (fr) 1999-10-14 2001-04-19 Pola Chemical Industries Inc. Compositions d'electroporation
CA2387370C (en) * 1999-10-15 2008-12-23 Pola Chemical Industries Inc. Percutaneous sorbefacients for electroporation
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
EP3228320B1 (de) 2008-10-17 2019-12-18 Sanofi-Aventis Deutschland GmbH Kombination von einem insulin und einem glp-1-agonisten
UY33025A (es) 2009-11-13 2011-06-30 Sanofi Aventis Deustschland Gmbh Composicion farmaceutica que comprende un agonista de glp-1 metionina
AR080669A1 (es) 2009-11-13 2012-05-02 Sanofi Aventis Deutschland Composicion farmaceutica que comprende un agonista de glp-1, una insulina y metionina
MX339614B (es) 2010-08-30 2016-06-02 Sanofi - Aventis Deutschland GmbH Uso de ave0010 para la fabricacion de un medicamento para el tratamiento de la diabetes mellitus tipo 2.
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
RU2650616C2 (ru) 2011-08-29 2018-04-16 Санофи-Авентис Дойчланд Гмбх Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
TWI559929B (en) 2011-09-01 2016-12-01 Sanofi Aventis Deutschland Pharmaceutical composition for use in the treatment of a neurodegenerative disease
CN107206058A (zh) 2014-12-12 2017-09-26 赛诺菲-安万特德国有限公司 甘精胰岛素/利西拉来固定比率配制剂
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第２型糖尿病病患之治療

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5506203C1 (en) * 1993-06-24 2001-02-06 Astra Ab Systemic administration of a therapeutic preparation
US5504188A (en) * 1994-06-16 1996-04-02 Eli Lilly And Company Preparation of stable zinc insulin analog crystals
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
CN1198643C (zh) * 1996-06-20 2005-04-27 诺沃挪第克公司 含碳水化合物的胰岛素制品
AU6611998A (en) * 1997-03-20 1998-10-20 Novo Nordisk A/S Therapeutic powder formulation for pulmonary administration, containing crystalline insulin

Also Published As

Publication number Publication date
EP1121145B1 (en) 2002-04-17
AU6189099A (en) 2000-05-08
WO2000023099A1 (en) 2000-04-27
UA67798C2 (uk) 2004-07-15
HUP0103606A2 (hu) 2002-02-28
KR20010080132A (ko) 2001-08-22
CZ20011133A3 (cs) 2001-08-15
PT1121145E (pt) 2002-09-30
AU758108B2 (en) 2003-03-13
NO20011841L (no) 2001-06-15
DE69901314D1 (de) 2002-05-23
EP1121145A1 (en) 2001-08-08
CN1323220A (zh) 2001-11-21
BR9914568A (pt) 2001-07-03
HUP0103606A3 (en) 2002-05-28
DK1121145T3 (da) 2002-08-12
PL347171A1 (en) 2002-03-25
JP2002527488A (ja) 2002-08-27
ATE216258T1 (de) 2002-05-15
CA2346884A1 (en) 2000-04-27
DE69901314T2 (de) 2002-11-21
ZA200102068B (en) 2001-10-12
NO20011841D0 (no) 2001-04-10
ES2177324T3 (es) 2002-12-01

Similar Documents

Publication Publication Date Title
IL142002A0 (en) Insulin preparation for pulmonary delivery containing menthol
WO1996017587A3 (en) Oral compositions containing stabilized stannous compounds
GEP20043258B (en) Systems and Methods for Aerosolizing Pharmaceutical Formulations
ES2091727A1 (es) Formulaciones de analogos de insulina.
ATE277630T1 (de) Stabile konzentrierte insulin präparationen zur pulmonaren verabreichung
MY131803A (en) Aerosolized active agent delivery
RU94040387A (ru) Композиция, способствующая прекращению курения, никотиносодержащий распыляемый раствор, способ снижения потребности в курении табака, способ замены курения табака
MY129112A (en) Flow resistance modulated aerosolized active agent delivery
MY114945A (en) Oral composition
BG105430A (en) Compositions and methods for the supply of powder active substance in the lungs
GR3034162T3 (en) Liposome-encapsulated taxol, its preparation and its use
ES2180511T3 (es) Formulaciones monodispersas de analogos de insulina acilados hexamericos.
IL140848A (en) Pharmaceutical compositions containing phenylacetylglutamine, phenylacetylisoglutamine and/or phenylacetate
ZA200205167B (en) gamma-IFN liquid-droplet aerosol and method.
AU2387092A (en) New pyrazine derivatives, their preparation and their use
AU2615795A (en) Compounds and compositions for administration via oral inhalation or insufflation
DE60103619D1 (de) Pharmazeutische zubereitungen enthaltend alginate
Morris et al. Regional distribution and kinetics of vinyl acetate hydrolysis in the oral cavity of the rat and mouse
JPS56108716A (en) Antiviral agent containing different kind dead cell mixture as effective component
EP0813879A3 (en) Drug administration composition for iontophoresis
JPS6470061A (en) Deodorant for livestock and its preparation
PL370860A1 (en) Aromatic herb preparation
SU1665561A1 (ru) Гербицидный состав
ES2023530A6 (es) Composicion desinfectante por via aerea.
JPS5739800A (en) Composition for measuring gpt